Expert Think Tank: Resources to Improve the Case of Patients With NSCLC and EGFR Mutations

Gain expert insights on challenges in and best practices for managing EGFR mutation–positive NSCLC with this comprehensive educational program, including expert-authored commentaries and text modules, an on-demand webcast of a CCO live webinar along with an FAQ audio podcast, a regularly updated downloadable teaching slideset, and downloadable clinical resource PDFs.

Share

Program Content

Activities

EGFR TKI Combos
Current Status of EGFR Tyrosine Kinase Inhibitor Combination Therapy in the Treatment of Newly Diagnosed EGFR-Mutated Advanced NSCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2021

Expires: December 02, 2022

View Activity
Uncommon <i>EGFR</i> Mutations
Management Strategies for Treating Patients With NSCLC and Uncommon EGFR Mutations
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 20, 2022

Expires: May 19, 2023

View Activity
Combos for EGFR Acquired Resistance
Rational Combination Strategies in the Treatment of EGFR-Mutated NSCLC With Acquired Resistance to EGFR TKI Therapy: Updates From ASCO 2022
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 13, 2022

Expires: July 12, 2023

View Activity
Adjuvant Osimertinib
My Thoughts Regarding Use of Adjuvant Osimertinib for Early-Stage EGFR Mutation–Positive NSCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 24, 2022

Expires: October 23, 2023

View Activity

Activities

<i>EGFR</i>+ NSCLC Care
Resources to Improve the Care of Patients With NSCLC and EGFR Mutations
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 21, 2022

Expires: September 20, 2023

View Activity

Activities

Expert Think Tank on <i>EGFR</i>m NSCLC: Module
Expert Think Tank: Lung Cancer Experts Discuss Current Standard of Care and Ongoing Challenges in the Care of Patients With EGFR-Mutated NSCLC
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: September 30, 2022

Expires: September 29, 2023

View Activity
Expert Think Tank <i>EGFR</i>m NSCLC: Slides
Expert Think Tank: Current Standard of Care and Ongoing Challenges in the Care of Patients With EGFR-Mutated NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 30, 2022

Expires: September 29, 2023

View Activity
<em>EGFR</em>-m Adv NSCLC Key Trials: Module
Key Emerging Treatment Strategies for Patients With EGFR-Mutated Advanced NSCLC
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: September 30, 2022

Expires: September 29, 2023

View Activity
<em>EGFR</em>m Adv NSCLC Key Trials: Slides
Key Emerging Treatment Strategies for Patients With EGFR-Mutated Advanced NSCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 30, 2022

Expires: September 29, 2023

View Activity

Activities

<i>EGFR</i>+ Adv NSCLC SoC Resource
EGFR-Mutated Advanced NSCLC: Standard of Care Overview
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 24, 2022

Expires: May 23, 2023

View Activity
<i>EGFR</i>+ Adv NSCLC: Future Directions
Clinical Research Spotlight for EGFR-Mutated NSCLC
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 24, 2022

Expires: May 23, 2023

View Activity
NSCLC Biomarker Resource
Best Practices and Recommendations for Molecular Testing in Advanced NSCLC (May 2022)
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 24, 2022

Expires: May 23, 2023

View Activity

Activities

<i>EGFR</i>+ NSCLC Webcast
Resources to Improve the Care of Patients With NSCLC and EGFR Mutations
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: October 24, 2022

Expires: October 23, 2023

View Activity

Activities

FAQs on EGFR-Mutated NSCLC
Managing EGFR-Mutated Non-Small-Cell Lung Cancer in Today’s Clinic: Expert Answers to Frequently Asked Questions
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: September 28, 2022

Expires: September 27, 2023

View Activity

Faculty

cover img faculity

Edward B. Garon, MD, MS

Professor
Director,
Thoracic Oncology Program
Division of Hematology/Oncology
David Geffen School of Medicine at UCLA
Director, Signal Transduction and Therapeutics
Division of Hematology/Oncology
Department of Medicine
Jonsson Comprehensive Cancer Center at UCLA
Los Angeles, California

cover img faculity

Ryan D. Gentzler, MD, MS

Associate Professor
Division of Hematology/Oncology
Department of Medicine
University of Virginia
Thoracic Medical Oncologist
University of Virginia Comprehensive Cancer Center
Charlottesville, Virginia

cover img faculity

Xiuning Le, MD, PhD

Assistant Professor
Division of Cancer Medicine
Department of Throracic/Head & Neck Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Joel W. Neal, MD, PhD

Associate Professor of Medicine
Division of Oncology
Department of Medicine
Stanford University
Attending Physician
Stanford Cancer Institute
Palo Alto, California

cover img faculity

Zofia Piotrowska, MD

Assistant Professor of Medicine
Massachusetts General Hospital Cancer Center
Harvard Medical School
Boston, Massachusetts

cover img faculity

David Planchard, MD, PhD

Head of Thoracic Group
Department of Medical Oncology
Gustave Roussy
Villejuif, France

cover img faculity

Jonathan Riess, MD, MS

Associate Professor
Division of Hematology-Oncology
Department of Internal Medicine
UC Davis
Medical Director
Thoracic Oncology
UC Davis Comprehensive Cancer Center
Sacramento, California

cover img faculity

Julia Rotow, MD

Clinical Instructor
Thoracic Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Catherine A. Shu, MD

Associate Professor of Medicine
Department of Hematology/Oncology
Clinical Director
Thoracic Medical Oncology
Columbia University Medical Center
New York, New York

cover img faculity

Mark A. Socinski, MD

Director, Lung Cancer Section of the Division of Hematology/Oncology
Co-Director, UPMC Center for Excellence in Lung Cancer
Co-Director, Lung and Thoracic Malignancies Program
University of Pittsburgh Cancer Institute
University of Pittsburgh
Pittsburgh, Pennsylvania

cover img faculity

Helena Yu, MD

Associate Attending
Research Director of Thoracic Oncology Service
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Lilly